Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
0.323
+0.015 (4.94%)
At close: Dec 20, 2024, 4:00 PM
0.303
-0.020 (-6.26%)
After-hours: Dec 20, 2024, 7:50 PM EST
Venus Concept Employees
Venus Concept had 304 employees as of December 31, 2023. The number of employees decreased by 80 or -20.83% compared to the previous year.
Employees
304
Change (1Y)
-80
Growth (1Y)
-20.83%
Revenue / Employee
$221,053
Profits / Employee
-$164,957
Market Cap
2.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Regional Health Properties | 114 |
Xylo Technologies | 84 |
Fresh2 Group | 75 |
NovaBay Pharmaceuticals | 26 |
Biodexa Pharmaceuticals | 21 |
Catheter Precision | 14 |
Palisade Bio | 9 |
Shuttle Pharmaceuticals Holdings | 8 |
VERO News
- 5 weeks ago - Venus Concept Inc. (VERO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India - GlobeNewsWire
- 2 months ago - Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024 - GlobeNewsWire
- 3 months ago - Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction - GlobeNewsWire
- 3 months ago - Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX - GlobeNewsWire
- 4 months ago - Venus Concept Inc. (VERO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Venus Concept Announces Second Quarter of Fiscal Year 2024 Financial Results - GlobeNewsWire